Immunological Cross‐Reactivity and Neutralizing Efficacy of Antivenom Against Five Medically Important Iranian Viper Venoms [PDF]
Veterinary Medicine and ScienceBackground Antivenom efficacy relies on the venom antigen composition and the range of antibody cross‐reactivity. This research compared the biochemical profiles of five medically relevant Iranian vipers, Gloydius caucasicus, Pseudocerastes persicus ...
Sedigheh Khamehchian +4 more
doaj +3 more sources
An investigation of snakebite antivenom usage in Taiwan [PDF]
Journal of the Formosan Medical Association, 2016 Four types of antivenom are used to treat snakebites by the six species of venomous snakes native to Taiwan. Research into antivenom use in Taiwan and its outcomes, as well as the utility of current Taiwan Poison Control Center guidelines for antivenom ...
Chih-Chuan Lin
exaly +4 more sources
Antivenom availability, delays and use in Australia
Toxicon: X, 2023 Antivenom is the main treatment for snake envenoming and there are ongoing concerns about availability in resource poor regions of the world. However, effective antivenom treatment for snake envenoming requires more than improved availability of safe and
Geoffrey Isbister
exaly +3 more sources
Polyspecific snake antivenom may help in antivenom crisis [PDF]
BMJ, 2003 EDITOR—In Africa snakebites cause thousands of deaths annually and much permanent physical disability, but the supply of antivenom, the only specific treatment, is threatened by commercial pressures and privatisation. This has been caused over the past few years by the cessation of antivenom manufacture by Behringwerke in Germany, greatly reduced ...
Laing, G +6 more
openaire +6 more sources
Analysis of factors influencing skin sensitivity test results of antivenom and its potential correlation with allergic reactions: a retrospective cohort study [PDF]
Frontiers in AllergyBackgroundSnakebite remains a persistent public health concern, whether skin sensitivity testing for antivenom should be performed remains a subject of debate.
Haoyu Wang +4 more
doaj +2 more sources
Adverse Reactions after Administration of Antivenom in Korea
Toxins, 2020 Kovax® antivenom is the main treatment for toxins produced by the Gloydius species. However, research on adverse reactions after Kovax® antivenom administration is scarce.
Jin Seok Shim +4 more
doaj +2 more sources
Antivenom supply and demand: An analysis of antivenom availability and utilization in South Africa
African Journal of Emergency Medicine, 2023 Snakebites are a neglected tropical disease. In many areas, envenoming incidence and antivenom administration rates are unknown. This study compared antivenom (AV) availability to rates of envenoming and recommendations to treat (RTT) in South Africa.This retrospective study identified, extracted, and reviewed all cases of envenoming (snake bites and ...
Natalie R Neumann +6 more
openaire +4 more sources
Dose and time dependence of box jellyfish antivenom [PDF]
Journal of Venomous Animals and Toxins including Tropical Diseases, 2014 Background The effectiveness of the currently available box jellyfish (Chironex fleckeri) antivenom has been subject of debate for many years. To assess whether the box jellyfish antivenom has the ability to attenuate venom-induced damage at cellular ...
Athena Andreosso +2 more
doaj +2 more sources
Pharmacological Treatments and Adverse Reactions Following Snake Antivenom Therapy: A Collaborative Study by Healthcare Professionals in the Southernmost Region of Thailand [PDF]
ToxinsThe administration of specific immunoglobulin G-based antivenoms is a key strategy for treating snakebite envenoming victims. However, serious adverse reactions, such as anaphylaxis or serum sickness, are frequently observed following such administration.
Panuwat Promsorn +3 more
doaj +2 more sources
Early Adverse Reactions to Snake Antivenom: Poison Center Data Analysis
Toxins, 2022 Antivenom is an essential treatment for snake envenomation; however, early adverse reactions (EARs) are major limitations to its use. We performed a retrospective cross-sectional study using Ramathibodi Poison Center data (January 2016 to December 2017 ...
Charuwan Sriapha +5 more
doaj +2 more sources